Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other neoplasm 1

Conditions

Precancerous Conditions 214Lymphoma 47Leukemia 46Multiple Myeloma 44Leukemia, Lymphocytic, Chronic, B-Cell 42Neoplasms, Plasma Cell 40Precursor Cell Lymphoblastic Leukemia-Lymphoma 39Monoclonal Gammopathy of Undetermined Significance 39Lymphoma, Non-Hodgkin 38Lymphoma, Mantle-Cell 37Lymphoma, Large-Cell, Immunoblastic 37Lymphoma, Large B-Cell, Diffuse 37Lymphoma, Follicular 37Myelodysplastic Syndromes 36Burkitt Lymphoma 36Lymphoma, B-Cell, Marginal Zone 35Leukemia, Myeloid, Acute 35Hodgkin Disease 35Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 34Myeloproliferative Disorders 34Immunoglobulin Light-chain Amyloidosis 33Waldenstrom Macroglobulinemia 32Immunoblastic Lymphadenopathy 32Uterine Cervical Neoplasms 31Lymphoma, Large-Cell, Anaplastic 31Primary Myelofibrosis 30Thrombocythemia, Essential 29Leukemia, Hairy Cell 29Leukemia, Biphenotypic, Acute 29Uterine Cervical Dysplasia 28

Interventions

thymoglobulin 1fludarabine phosphate 1fludarabine 1Whole-Body Irradiation 1Stem Cell Transplantation 1Sirolimus 1Mycophenolic Acid 1Hematopoietic Stem Cell Transplantation 1Cyclophosphamide 1Antilymphocyte Serum 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Non-Malignant Neoplasm × Other neoplasm × Clear all
NCT04083183 2025-12-18

Total Body Irradiation and Astatine-211-Labeled BC8-B10 Monoclonal Antibody for the Treatment of Nonmalignant Diseases

Fred Hutchinson Cancer Center

Phase 1/2 Recruiting
40 enrolled
Other neoplasm

Non-Malignant Neoplasm

Data powered by HemOnc (CC BY 4.0) Colophon âš¡